(Q34017538)

30 July 2017

title

A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias (English)

1 reference

30 July 2017

1 reference

1 reference

Mucuna pruriens

1 reference

inferred from title

parkinsonian syndrome

1 reference

Christopher A Lieu

1

1 reference

30 July 2017

Allen R Kunselman

2

1 reference

30 July 2017

Bala V Manyam

3

1 reference

30 July 2017

Kala Venkiteswaran

4

1 reference

30 July 2017

Thyagarajan Subramanian

5

1 reference

30 July 2017

publication date

31 May 2010

1 reference

30 July 2017

number of pages

8

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

30 July 2017

volume

16

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

458-465

1 reference

Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

Behavioral tests for preclinical intervention assessment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

Effect of antiparkinson drug HP-200 (Mucuna pruriens) on the central monoaminergic neurotransmitters

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

Traditional and complementary therapies in Parkinson's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

Medical and Ecological Considerations of L-Dopa and 5-HTP in Seeds

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

Paralysis agitans and levodopa in "Ayurveda": ancient Indian medical treatise

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

The inhibitory effect of the cowhage plant-Mucuna pruriens-and L-dopa on chlorpromazine-induced hyperprolactinaemia in man.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

Evaluation of behavioural effects of a selective NMDA NR1A/2B receptor antagonist in the unilateral 6-OHDA lesion rat model.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

Isolation of l-3:4-dihydroxyphenylalanine from the seeds of Mucuna pruriens

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

Predictors of gastric emptying in Parkinson's disease.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioral deficits without provoking a host immune response

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

Association of L-DOPA with recovery following Ayurveda medication in Parkinson's disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

Mucuna pruriens: improvement of the biotechnological production of the anti-Parkinson drug L-dopa by plant cell selection

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909380

Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test

29 October 2018

1 reference

12 December 2020

1 reference

12 December 2020

Pathophysiological basis of drug-induced dyskinesias in Parkinson's disease

1 reference

12 December 2020

Estimation of L-dopa from Mucuna pruriens LINN and formulations containing M. pruriens by HPTLC method

1 reference

12 December 2020

Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism

1 reference

12 December 2020

Activity of bromoergocryptine, Mucuna pruriens and L-dopa in the control of hyperprolactinaemia

1 reference

12 December 2020

An alternative medicine treatment for Parkinson's disease: results of a multicenter clinical trial. HP-200 in Parkinson's Disease Study Group

1 reference

12 December 2020

CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury

1 reference

12 December 2020

Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy

1 reference

12 December 2020

Mucuna pruriens proves more effective thanl-DOPA in Parkinson's disease animal model

1 reference

11 May 2024

https://opencitations.net/index/api/v1/citations/10.1002/(SICI)1099-1573(199709)11:6%3C419::AID-PTR120%3E3.0.CO;2-Q

Identifiers

DOI

10.1016/J.PARKRELDIS.2010.04.015

1 reference

30 July 2017

1 reference

30 July 2017

1 reference